Predicting joint involvement through tailored prophylaxis in severe haemophilia A, is it possible?
ORIGINAL ARTICLE Predicting joint involvement through tailored prophylaxis in severe…
Ler MaisType 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies
Type 1 VWD classification revisited: novel insights from combined analysis…
Ler MaisPredicting joint involvement through tailored prophylaxis in severe haemophilia A, is it possible?
Predicting joint involvement through tailored prophylaxis in severe haemophilia A,…
Ler MaisExploring the effects of Factor Xa inhibitors on thrombin generation in people with haemophilia
Exploring the effects of Factor Xa inhibitors on thrombin generation…
Ler MaisCongenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of…
Ler MaisGuideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the United Kingdom Haemophilia Centre Doctors’ Organisation and the British Society for Haematology
Guideline for laboratory diagnosis and monitoring of von Willebrand disease:…
Ler Mais
Tromboembolismo venoso: casos da prática clínica para definir o papel da anticoagulação parentérica
Tromboembolismo venoso: casos da prática clínica para definir o papel…
Ler Mais2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic…
Ler MaisCancer patients and ischemic stroke
Cancer patients and ischemic stroke Tomohiro Kawano a, Nigel Mackman b a Department of Neurology,…
Ler MaisAntithrombin exhibits anticoagulant effects on the emicizumab-based engineered bispecific antibody (NXT007)-mediated blood coagulation
Letter to the Editors-in chief Antithrombin exhibits anticoagulant effects on…
Ler Mais